About Ryan
Ryan Taylor is a senior associate in Arnold Bloch Leibler’s Corporate, M&A and Capital Markets practice group in Melbourne.
Ryan’s transactional experience involves advising ASX-listed entities, large privately held companies, high net-worth individuals and entrepreneurs on public and private acquisition opportunities, equity raisings, corporate governance and general advisory matters. Ryan acts for clients in several prominent and dynamic industries, including technology, pharmaceuticals, wagering and retail.
Ryan joined Arnold Bloch Leibler in 2020 and was admitted to practice in 2021. Ryan holds a Bachelor of Arts and Bachelor of Law with Honours from Monash University.
Practice focus
Ryan’s practice focuses on the following areas:
- mergers and acquisitions
- public listings and equity capital markets
- asset and share acquisitions and disposals
- listed and private corporate governance, compliance and advisory
- strategic investments and stakeholder agreements, and
- general commercial and corporate advice.
Experience
Ryan has advised on a range of matters, including:
ASX-listed / M&A transactions
- betr Entertainment Limited: in relation to its off-market takeover to acquire ASX-listed rival, PointsBet Holdings Limited and selective buy-back
- Canaccord Genuity Australia: in relation to its acquisition of Wilsons Advisory
- Premier Investments Limited: in relation to the $1 billion merger between Myer and Premier’s Apparel Brands Business comprising Just Jeans, Jay Jays, Portmans, Jacqui E and Dotti
- Premier Investments Limited: in relation to the proposed demerger of Smiggle into a separate listed entity
- betr: in relation to its landmark $50 million merger with ASX-listed BlueBet Holdings Limited (now betr Entertainment Limited) and associated $20 million capital raising
- BlueBet Holdings Limited: in relation to its acquisition of TopSport and associated $15 million capital raising
- Praemium Limited: in relation to the divestment of its operations in the United Kingdom, Jersey, Hong Kong and Dubai to Morningstar Inc
Private M&A transactions
- National Veterinary Associates Inc: in relation to the sale by European private equity firm JAB to EQT Group of VetPartners, Australia and New Zealand’s largest provider of veterinary and animal health services
- GenesisCare: acted as Australian counsel for the new major equity owners of GenesisCare, one of Australia’s largest providers of cancer services, in connection with a debt-for-equity swap as part of GenesisCare’s US$2.1 billion restructure
- ME Bank: in relation to the $1.325 billion sale by 26 Australian industry super funds to Bank of Queensland Ltd
- Parc Capital: in relation to the merger of allied health services business Kinela with Humanity Health Group
- TMG Developments: in relation to the sale of the Manly Wharf retail and hospitality facility and hotel business
- Private client: in relation to the sale of Bevington Group to global management consultancy Argon & Co ANZ
- Superhero Holdings Limited: in relation to its merger and subsequent demerger with cryptocurrency business Swyftx
- Booktopia Group Limited: acted for the administrators, McGrathNicol, in relation to the sale of Booktopia’s business and related assets
- Tripp Group and Tekkorp Holdings: in relation to the launch of a new Australian online wagering business, betr
Capital Markets transactions
- Epiminder Limited: in relation to its ASX Listing and $125 million IPO raising
- betr Entertainment Limited: in relation to its $130 million capital raising, comprising a fully underwritten placement and ANREO
- Freedom Foods Group Limited: in relation to its $265 million recapitalisation by way of secured convertible notes and senior debt restructure;
- BlueBet Holdings Limited: in relation to its acquisition of TopSport and associated $15 million capital raising
- com Ltd: in relation to its $100 million placement and SPP
- noumi Limited: in relation to its $27 million capital raising by way of secured convertible notes
- Neuren Pharmaceuticals Limited: in relation to its $20 million capital raising
- Hexima Limited: in relation to its ASX listing, share sale facility and institutional placement
